The participants of the meeting discussed the regional cooperation, the latest developments of drug policy and drug situation in the EU and Central Asia and reviewed the implementation of the EU-Central Asia Drug Action Plan 2014-2020. The participants from Central Asia made their input to the discussion about drug demand and drug supply reduction.
A few days earlier, the delegations from Central Asia were invited to Trimbos Institute in Amsterdam, the Netherlands. They got acquainted with the current developments and discussions about the Dutch and European as well as international drug policies. They learned more about synthetic drugs and the EU supply reduction policies. CADAP partners from Central Asia also provided short reflections on the Drug Assessment Reports published earlier by CADAP, and updated the information on recent developments in their countries.
They also discussed how CADAP can provide assistance to Central Asia in drug policy making.
CADAP 6 represents continuity of the EU policy and long-term engagement with Central Asian partners to help further strengthen their national strategies in drug supply and drug demand reduction policies. The programme is funded by the European Union and implemented by the Consortium from the Netherlands, Czech Republic, Poland and Germany, led by the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH.
For more information, please contact: Ms. Asel Sekimova, Public Relations Professional, by phone (996 770) 444 068, or e-mail: email@example.com